GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Fixed Maturity Investment

BCAX (Bicara Therapeutics) Fixed Maturity Investment


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics Fixed Maturity Investment?

Fixed Maturity Investment only applies to insurance companies.


Bicara Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Website
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.